Agilon Health, Inc.
Agilon Health, Inc. (AGL) Revenue
Annual & quarterly revenue history · segment & region breakdown
AGL · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsAgilon Health, Inc. trailing twelve-month (TTM) revenue is $5.82B, a decrease of 2.11% year-over-year from $5.93B in FY2025.
Revenue trend
2025 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $5.93B | -$0.13B | -2.11% |
| 2024-12-31 | $6.06B | +$1.74B | +40.41% |
| 2023-12-31 | $4.32B | +$1.93B | +80.74% |
| 2022-12-31 | $2.39B | +$0.87B | +56.97% |
| 2021-12-31 | $1.52B | +$0.30B | +24.88% |
| 2020-12-31 | $1.22B | +$0.42B | +53.36% |
| 2019-12-31 | $0.79B | — | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Agilon Health, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Agilon Health, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Agilon Health, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
AGL revenue · 4 questionsAGL's trailing twelve-month (TTM) revenue is $5.82B. That is a decrease of 2.11% year-over-year from $5.93B in FY2025.
▸ Source: FMP · Agilon Health, Inc. SEC filings · GAAP · Agilon Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026